255 related articles for article (PubMed ID: 18566213)
21. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
Tiwary R; Yu W; Sanders BG; Kline K
Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
[TBL] [Abstract][Full Text] [Related]
22. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
Sasaki H; Sheng Y; Kotsuji F; Tsang BK
Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop.
Castino R; Peracchio C; Salini A; Nicotra G; Trincheri NF; Démoz M; Valente G; Isidoro C
J Cell Mol Med; 2009 Jun; 13(6):1096-109. PubMed ID: 18657225
[TBL] [Abstract][Full Text] [Related]
25. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation.
Melino G; Bernassola F; Ranalli M; Yee K; Zong WX; Corazzari M; Knight RA; Green DR; Thompson C; Vousden KH
J Biol Chem; 2004 Feb; 279(9):8076-83. PubMed ID: 14634023
[TBL] [Abstract][Full Text] [Related]
26. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines.
Tsuruta Y; Mandai M; Konishi I; Kuroda H; Kusakari T; Yura Y; Hamid AA; Tamura I; Kariya M; Fujii S
Eur J Cancer; 2001 Mar; 37(4):531-41. PubMed ID: 11267864
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis by hydrogen peroxide in HPV 16 positive human cervical cancer cells: involvement of mitochondrial pathway.
Singh M; Singh N
Mol Cell Biochem; 2008 Mar; 310(1-2):57-65. PubMed ID: 18060474
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and -independent pathways.
Kim JS; Lee JM; Chwae YJ; Kim YH; Lee JH; Kim K; Lee TH; Kim SJ; Park JH
Biochem Pharmacol; 2004 Apr; 67(8):1459-68. PubMed ID: 15041463
[TBL] [Abstract][Full Text] [Related]
29. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
Yang H; He L; Kruk P; Nicosia SV; Cheng JQ
Int J Cancer; 2006 Nov; 119(10):2304-12. PubMed ID: 16894566
[TBL] [Abstract][Full Text] [Related]
30. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
[TBL] [Abstract][Full Text] [Related]
31. Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells.
Righetti SC; Perego P; Carenini N; Zunino F
Cancer Lett; 2008 May; 263(1):140-4. PubMed ID: 18261847
[TBL] [Abstract][Full Text] [Related]
32. Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.
Yang X; Wang J; Zhou Y; Wang Y; Wang S; Zhang W
Cancer Lett; 2012 Aug; 321(2):137-43. PubMed ID: 22281241
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53.
Vikhanskaya F; Clerico L; Valenti M; Stanzione MS; Broggini M; Parodi S; Russo P
Int J Cancer; 1997 Jul; 72(1):155-9. PubMed ID: 9212237
[TBL] [Abstract][Full Text] [Related]
34. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
[TBL] [Abstract][Full Text] [Related]
35. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
36. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
Zhang P; Liu SS; Ngan HY
PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
[TBL] [Abstract][Full Text] [Related]
37. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
38. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Lee CS; Yang JC; Kim YJ; Jang ER; Kim W; Myung SC
Eur J Pharmacol; 2010 Dec; 649(1-3):354-61. PubMed ID: 20868669
[TBL] [Abstract][Full Text] [Related]
39. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
[TBL] [Abstract][Full Text] [Related]
40. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]